Yash Sunil Chari has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech promoter Sunil Srinivasan Chari is gifting 88,00,000 equity shares (15.89% of paid-up capital) to three members of the promoter group — his son Yash Sunil Chari (23 lakh shares, 4.15%), wife Jyotishna Sunil Chari (15 lakh shares, 2.71%), and the Chari Family Trust (50 lakh shares, 9.03%). The transfer is an off-market inter-se move within the promoter family at no consideration, exempted under Regulation 10(1)(a)(i) of SEBI SAST Rules. Sunil Srinivasan Chari's personal holding drops from 29.06% to 13.17%, while the aggregate promoter and promoter group holding stays unchanged. The shares are expected to be transferred on or after August 28, 2025.
This is a family-level reshuffle, not a change in promoter control — total promoter group stake remains the same, so there is no impact on stock price or minority shareholders. Investors should note that the original promoter's personal stake is being diluted within the family, with the Chari Family Trust emerging as a significant holder at 9.23%.